11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
about
Murine models of acute leukemia: important tools in current pediatric leukemia research.Cytogenetics and molecular genetics of childhood leukemia.Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaChildhood leukemia: Understanding the significance of chromosomal abnormalities.Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation.Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis.Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partnersCentral nervous system prophylaxis in haematological malignancies.Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology GroupA case of therapy-related acute lymphoblastic leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 gene rearrangementNew markers for minimal residual disease detection in acute lymphoblastic leukemia.The molecular genetics of hematologic malignanciesMLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children's Oncology Group (COG) study.Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.RNA interference as a potential tool in the treatment of leukaemia.Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in developmentGenetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.Molecular genetics of B-precursor acute lymphoblastic leukemiaNF-kappaB activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemiaBALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia.Histone H3K4 methylation regulates deactivation of the spindle assembly checkpoint through direct binding of Mad2Pseudo-rearrangement of the MLL gene at chromosome 11q23: a cautionary note on genotype analysis of leukaemia patients.The evolution of clinical trials for infant acute lymphoblastic leukemia.Epigenetic regulation of miRNA genes in acute leukemia.Mixed lineage leukemia protein in normal and leukemic stem cells.Mechanisms of mixed-lineage leukemia.Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13).Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent manner.Molecular analysis of infant acute leukemia.Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements.Acute lymphoblastic leukaemiaLong Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy
P2860
Q33606018-309BD8CE-8167-4E4F-998E-97220E762F38Q33820790-3CFBEB12-360A-44C9-B57A-99BB60D4B56BQ33985127-7B37CC5C-B2D1-4C3C-BB81-B0DC39F5656DQ34261941-861403AC-B79E-4FE2-AA66-FA0B265A8D3BQ34273628-3AC31A9A-FE5D-48E8-BBD2-BD65B064A3EFQ34278721-3F98B2EE-A0C9-4D70-9724-9B2234B2A82AQ34532636-90F36D81-16D4-4198-8CF0-0F282C52BE6AQ34620470-AF2BBD3F-2D27-41EF-91DC-09452A081BFEQ34660525-21C2F77F-D058-4BF5-9F17-8526269A3312Q34679190-15EFF98D-A73E-49D8-89BD-AA9B559173B5Q35034197-813EC22F-14AD-41F2-9C52-7DD270640CB3Q35067391-8A40B112-B667-41C6-BDC3-D25B6894D573Q35224361-D6FB4E46-9101-4305-A900-6A4B054AF591Q35523692-32C726F9-332F-4DF0-B5FC-F7FEF7043C13Q35847465-418A7346-D3DA-4BBD-A58B-AEA509C056EAQ35967287-D241C610-EDEA-4BCF-9C29-7C4547763C15Q35967452-7B5EC0A3-3945-4A3E-93C7-CA42C7095D2FQ36054879-83CA5E6C-8D6B-41F3-8655-CFA90A7A3494Q36290242-A50658DC-EB9C-4E48-A74D-A7DE7E3F060AQ36311738-0E3937E4-8250-4ECC-9BAB-2407E304608AQ36397963-4161987A-3F00-4749-839E-7D54A7D4B1CBQ36955942-D2D4B506-56BB-4D00-8A40-AB008D7BCF59Q37640862-5D9733B0-197D-4CE9-8487-C2299EFC6812Q37730023-433118A6-91E2-4541-8B2C-EC4DDFE1CD74Q37965026-9309447E-380B-454E-A035-31072B923155Q38100107-0A9DE309-D482-4FCE-8FB4-CAF2B438A94DQ38190545-CD15D00A-089F-4685-A357-083A2C5384CEQ38301654-0DE45C33-448A-474F-A5E5-687F41470EC6Q38676263-D7986891-716B-41FD-9654-DB3F830E607EQ40270156-19317790-38CB-4CC6-80D8-FD0CED30629BQ41486048-1E3AAD72-98C0-4D89-8DE6-B8D612BEEFFAQ47729253-C57956DB-40B0-4DBB-BFDE-C46EC7F3BEC1Q53586148-AC453795-94E3-4D5E-ACF5-2C70CECC8AA2Q53607290-F0B24658-D5DD-4BC3-93D9-785F9F9A0B1AQ54295411-DF2D7270-3162-4B14-8258-97DBD0647E83Q58481753-A991EC15-2698-4924-B804-8A7E27867BF0Q58725483-ACFFD994-D6DC-4661-9876-831E76C81148
P2860
11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@ast
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@en
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@nl
type
label
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@ast
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@en
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@nl
prefLabel
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@ast
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@en
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@nl
P2093
P1476
11q23/MLL rearrangement confer ...... acute lymphoblastic leukemia.
@en
P2093
H H Mahmoud
J R Downing
J T Sandlund
M L Hancock
R C Ribeiro
S A Shurtleff
W L Furman
P304
P356
10.1200/JCO.1994.12.5.909
P407
P577
1994-05-01T00:00:00Z